Does MESTEROLONE Cause Focal segmental glomerulosclerosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Focal segmental glomerulosclerosis have been filed in association with MESTEROLONE. This represents 13.2% of all adverse event reports for MESTEROLONE.
5
Reports of Focal segmental glomerulosclerosis with MESTEROLONE
13.2%
of all MESTEROLONE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From MESTEROLONE?
Of the 5 reports, 5 (100.0%) required hospitalization, and 4 (80.0%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MESTEROLONE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does MESTEROLONE Cause?
Drug abuse (19)
Secondary hypogonadism (10)
Autoimmune thyroiditis (9)
Diabetes mellitus (9)
Off label use (8)
Product use in unapproved indication (8)
Haematocrit increased (7)
Performance enhancing product use (7)
Blood glucose increased (6)
Glucose tolerance decreased (6)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)